REG - Immupharma PLC - TR-1 Notification of major holdings

ImmuPharmaAnnouncement

11/06/2020 12:00

RNS Number : 6729P
  
Immupharma PLC
  
11 June 2020
  
 

 
ImmuPharma PLC
("ImmuPharma" or the "Company")
Director/PDMR Shareholding
ImmuPharma (LSE:IMM) announces that on 11 June 2020, Dr Robert Zimmer, a Director of the Company, transferred 20,000,000 ordinary shares of 10 pence each ("Ordinary Shares") to Luca & Associates AG, an entity connected with Dr Zimmer, and of which he is President and a shareholder.
Following this transaction, Dr Zimmer remains interested in 27,344,514 Ordinary Shares as follows:




Shareholder


Number of Ordinary Shares


% of issued share capital




Dr R Zimmer


4,551,553


2.49%




Mrs E Zimmer


792,961


0.43%




Luca & Associates AG


22,000,000


12.02%




Total


27,344,514


14.94%




 
For further information please contact:
 




ImmuPharma PLC (www.immupharma.com)
Tim McCarthy, Chairman


+ 44 (0) 207 152 4080




Dimitri Dimitriou, Chief Executive Officer


 




Lisa Baderoon, Head of Investor Relations


+ 44 (0) 7721 413496
 




 
SPARK Advisory Partners Limited (NOMAD)
Neil Baldwin
Henry Todd
 
Stanford Capital Partners (Joint Broker)
Patrick Claridge, John Howes
 
SI Capital (Joint Broker)
Nick Emerson
 


 
+44 (0) 203 368 3554
 
 
 
+44 (0) 203 815 8880
 
 
 
+44 (0) 1483 413500
 




4Reliance (Euronext Growth Listing Sponsor)
Jean-Charles Snoy
 
Degroof Petercam (Liquidity Provider)
Erik De Clippel
 
Backstage Communication
Olivier Duquaine
Jean-Louis Dubrule


+32 (0) 2 747 02 60
 
 
+32 (0) 2 287 95 34
 
 
 
+32 (0) 477 504 784
+32 (0) 497 50 84 03
 




 


 




 


 




 


 



 
 
 
 
 



 
 
TR-1: Standard form for notification of major holdings
 




NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i




 




1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: 


ImmuPharma PLC




1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)




Non-UK issuer


 




2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights


X




An acquisition or disposal of financial instruments


 




An event changing the breakdown of voting rights


 




Other (please specify)iii:  Transfer of shares


X




3. Details of person subject to the notification obligationiv




Name


Luca & Associates AG




City and country of registered office (if applicable)


 




4. Full name of shareholder(s) (if different from 3.)v




Name


 




City and country of registered office (if applicable)


 




5. Date on which the threshold was crossed or reachedvi:


11 June 2020




6. Date on which issuer notified (DD/MM/YYYY):


11 June 2020




7. Total positions of person(s) subject to the notification obligation




 


% of voting rights attached to shares (total of 8. A)


% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)


Total of both in % (8.A + 8.B)


Total number of voting rights of issuervii




Resulting situation on the date on which threshold was crossed or reached


12.02%


 


12.02%


183,010,920




Position of previous notification (if 
applicable)


 


 


 


 



 
 
 
 
 
 
 



 




8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii




A: Voting rights attached to shares




Class/type of

shares
ISIN code (if possible)


Number of voting rightsix


% of voting rights




Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)




GB0033711010


22,000,000


 


12.02%


 




 


 


 


 


 




 


 


 


 


 




SUBTOTAL 8. A


22,000,000


12.02%




 
 




B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Periodxi


Number of voting rights that may be acquired if the instrument is 
exercised/converted.


% of voting rights




 


 


 


 


 




 


 


 


 


 




 


 


 


 


 




 


 


SUBTOTAL 8. B 1


 


 




 
 




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Period xi


Physical or cash 
settlementxii


Number of voting rights 


% of voting rights




 


 


 


 


 


 




 


 


 


 


 


 




 


 


 


 


 


 




 


 


 


SUBTOTAL 8.B.2


 


 




 
 
 



 
 
 
 
 
 
 
 
 
 



 




9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii


 




Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)


X




Namexv


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold




DR ZIMMER & OTHERS


2.92%


 


2.92%




LUCA & ASSOCIATES AG


12.02%


 


12.02%




 


 


 


 




 


 


 


 




TOTAL


14.94


 


14.94




 




10. In case of proxy voting, please identify:




Name of the proxy holder


 




The number and % of voting rights held


 




The date until which the voting rights will be held


 




 




11. Additional informationxvi




 
 
The notification has arisen as Dr Zimmer has transferred 20,000,000 shares to Luca & Associates AG, an entity connected with Dr Zimmer, and of which he is President and a shareholder.
 



 
 
 
 
 



 




Place of completion


5, rue du Rhône 68100 Mulhouse France




Date of completion


11 June 2020




 
 
TR-1: Standard form for notification of major holdings
 




NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i




 




1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: 


ImmuPharma PLC




1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)




Non-UK issuer


 




2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights


X




An acquisition or disposal of financial instruments


 




An event changing the breakdown of voting rights


 




Other (please specify)iii:  Transfer of shares


X




3. Details of person subject to the notification obligationiv




Name


Dr Robert Zimmer




City and country of registered office (if applicable)


 




4. Full name of shareholder(s) (if different from 3.)v




Name


 




City and country of registered office (if applicable)


 




5. Date on which the threshold was crossed or reachedvi:


11 June 2020




6. Date on which issuer notified (DD/MM/YYYY):


11 June 2020




7. Total positions of person(s) subject to the notification obligation




 


% of voting rights attached to shares (total of 8. A)


% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)


Total of both in % (8.A + 8.B)


Total number of voting rights of issuervii




Resulting situation on the date on which threshold was crossed or reached


14.94%


 


 


183,010,920




Position of previous notification (if 
applicable)


 


 


 


 



 
 
 
 
 
 
 



 




8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii




A: Voting rights attached to shares




Class/type of

shares
ISIN code (if possible)


Number of voting rightsix


% of voting rights




Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)




GB0033711010


5,344,514


22,000,000


2.92%


12.02%




 


 


 


 


 




 


 


 


 


 




SUBTOTAL 8. A


27,344,514


14.94%




 
 




B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Periodxi


Number of voting rights that may be acquired if the instrument is 
exercised/converted.


% of voting rights




 


 


 


 


 




 


 


 


 


 




 


 


 


 


 




 


 


SUBTOTAL 8. B 1


 


 




 
 




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Period xi


Physical or cash 
settlementxii


Number of voting rights 


% of voting rights




 


 


 


 


 


 




 


 


 


 


 


 




 


 


 


 


 


 




 


 


 


SUBTOTAL 8.B.2


 


 




 
 
 



 
 
 
 
 
 
 
 
 
 



 




9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii


x




Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)


 




Namexv


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold




 


 


 


 




 


 


 


 




 


 


 


 




 


 


 


 




 


 


 


 




 




10. In case of proxy voting, please identify:




Name of the proxy holder


 




The number and % of voting rights held


 




The date until which the voting rights will be held


 




 




11. Additional informationxvi




 
 
The notification has arisen as Dr Robert Zimmer has transferred 20,000,000 ordinary shares to Luca & Associates AG, an entity connected with Dr Robert Zimmer, and of which he is President and a shareholder.
 
Included in Dr Zimmer's holding are 792,961 shares in the name of his spouse Mrs Elizabeth Zimmer.
 



 
 
 
 
 



 




Place of completion


5, rue du Rhône 68100 Mulhouse France




Date of completion


11 June 2020




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
HOLEAPKFFLDEEEA